Skip to content
  • Home
  • Registration
  • Program
  • Main Topics
  • Faculty
  • List of Posters
  • Supporters
Contact us

Supporters

SupportersAdam Barkay2025-02-19T10:13:02+00:00
GOLD

Oncopeptides

Oncopeptides is a biotech company focusing on research, development and commercialization of targeted therapies for difficult-to-treat cancers. The company uses its proprietary Peptide Drug Candidate platform (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells.

Oncopeptides is developing several new compounds based on its proprietary technology platforms and is listed on Nasdaq Stockholm with the ticker ONCO. For more information see: www.oncopeptides.com

Oncopeptides Srl
Via Ceresio 7 – 20153 Milano
www.oncopeptides.it

SILVER
BRONZE

AbbVie

AbbVie‘s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.it @abbvie on LinkedIn.

Daiichi Sankyo

Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular and other diseases with high unmet medical need. For more information, please visit www.daiichi-sankyo.eu.

Daiichi Sankyo Europe GmbH
Zielstattstr. 48
81379 Munich
Tel: +49 89 78080
www.daiichi-sankyo.eu
[email protected]

Menarini Ricerche

Menarini Ricerche is a Research and Development hub of the Menarini Group.Together with Stemline Therapeutics, Menarini R&D is committed to innovation and patient care, focusing on the development of new personalised cancer drugs, as well as in new life science technologies aimed at non-invasive diagnosis to identify the best treatment option for each individual patient. Menarini develops projects from the preclinical phase to drug registration, including both small molecules and biologics, with a primary focus in Oncology. With research centers across Europe, the US, and Southeast Asia, Menarini invests heavily in research, personalized cancer treatments and advanced diagnostics.

Menarini Ricerche S.p.A.
Via Sette Santi
3 Firenze – Italy
Tel: +39 055 5680
www.menarini.com/en-us/innovation-research
[email protected]

Otsuka Pharmaceutical Italy Srl

Otsuka Pharmaceutical Italy Srl
Via Fabio Filzi 29
20124 Milano
Tel: +39 (0)2 00632 710
www.otsuka.it
SUPPORTERS

BeiGene

BeiGene, which plans to change its name to BeOne Medicines Ltd., is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of nearly 11,000 colleagues spans five continents. To learn more about BeiGene, please visit www.beigene.com and follow us on LinkedIn, X (formerly known as Twitter), Facebook and Instagram.

BeiGene Italy Srl
Piazzale Biancamano 8
20121, Milano
www.beigene.com

Bristol Meyers Squibb

Bristol Meyers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and make available innovative medicines dedicated to patients fighting serious diseases. We are inspired by a single vision: transforming patients’ lives through science. Patients are, in fact, at the center of everything we do; it is for them that we strive for scientific excellence, investing in research and development to make available innovative, high-quality medicines that meet unmet clinical needs.

Bristol Myers Squibb
Piazzale dell’Industri
40-46, 00144 Roma
Tel: +39 (0)6 503961

The 6th SOHO Italy Annual Conference

Conference venue

A. ROMA LIFESTYLE HOTEL
Via Giorgio Zoega, 59,
00164 Roma, Italy

© 2025 SOHO Italy. All Rights Reserved.

© 2025 SOHO Italy. All Rights Reserved.

Page load link

SOHO Italy 2025

  • Home
  • Registration
  • Program
  • Main Topics
  • Faculty
  • List of Posters
  • Supporters
Go to Top